Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Baclofen recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Baclofen (71 total). Check the affected lots below.

Most common reason: Sterility / contamination (52 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Baclofen. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Baclofen recalls on record

none so far in 2026; 71 on record, newest first
Class II · Moderate risk

Clonidine HCL and Baclofen in all strengths

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Terminated cGMP deviation Coast Quality Pharmacy, LLC dba Anazao Health D-0596-2020
Class II · Moderate risk

Baclofen and Morphine Sulfate in all strengths

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Terminated cGMP deviation Coast Quality Pharmacy, LLC dba Anazao Health D-0582-2020
Class II · Moderate risk

Baclofen in all strengths

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Terminated cGMP deviation Coast Quality Pharmacy, LLC dba Anazao Health D-0581-2020
Class II · Moderate risk

Gablofen (baclofen injection)

Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.

Terminated Impurity / degradation Piramal Critical Care, Inc. NDC 66794-151-01 D-1742-2019
Class II · Moderate risk

Baclofen USP

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8004-4 D-0476-2018
Class II · Moderate risk

All lidocaine

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1103-2016